> top > docs > PMC:3586680 > spans > 0-417 > annotations

PMC:3586680 / 0-417 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T41 17-21 Protein denotes WWOX
T42 26-29 Protein denotes p53
T59 17-21 Protein denotes WWOX
T60 26-29 Protein denotes p53
T67 382-386 Protein denotes WWOX
T66 374-378 Negative_regulation denotes Loss
T65 301-305 Protein denotes WOX1
T64 294-297 Protein denotes FOR
T63 288-292 Protein denotes WWOX
T62 252-287 Protein denotes WW domain-containing oxidoreductase
T61 106-109 Protein denotes p53
T48 382-386 Protein denotes WWOX
T47 301-305 Protein denotes WOX1
T46 294-297 Protein denotes FOR
T45 288-292 Protein denotes WWOX
T44 252-287 Protein denotes WW domain-containing oxidoreductase
T43 106-109 Protein denotes p53
R5 T63 T64 themeOf WWOX,FOR
R6 T64 T62 equivalentTo FOR,WW domain-containing oxidoreductase

testone

Id Subject Object Predicate Lexical cue
T19 17-21 Protein denotes WWOX
T20 26-29 Protein denotes p53
T38 392-402 Gene_expression denotes expression
T37 374-378 Negative_regulation denotes Loss
T26 382-386 Protein denotes WWOX
T25 301-305 Protein denotes WOX1
T24 294-297 Protein denotes FOR
T23 288-292 Protein denotes WWOX
T22 252-287 Protein denotes WW domain-containing oxidoreductase
T21 106-109 Protein denotes p53
R1 T26 T38 themeOf WWOX,expression
R4 T38 T37 themeOf expression,Loss

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T474 6-21 Protein denotes Suppressor WWOX
T475 26-29 Protein denotes p53
T482 374-378 Negative_regulation denotes Loss
T481 392-402 Gene_expression denotes expression
T480 382-391 Protein denotes WWOX gene
T479 301-305 Protein denotes WOX1
T478 294-297 Protein denotes FOR
T477 273-292 Protein denotes oxidoreductase WWOX
T476 106-109 Protein denotes p53
R239 T480 T481 themeOf WWOX gene,expression
R240 T481 T482 themeOf expression,Loss

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T552 0-5 NNP denotes Tumor
T553 6-16 NNP denotes Suppressor
T554 17-21 NNP denotes WWOX
T555 22-25 CC denotes and
T556 26-29 NN denotes p53
T557 30-41 NNS denotes Alterations
T558 42-45 CC denotes and
T559 46-50 NN denotes Drug
T560 51-61 NN denotes Resistance
T561 62-64 IN denotes in
T562 65-78 NNP denotes Glioblastomas
T620 406-416 RB denotes frequently
T619 403-405 VBZ denotes is
T618 392-402 NN denotes expression
T616 382-386 NNP denotes WWOX
T615 379-381 IN denotes of
T614 374-378 NN denotes Loss
T613 372-373 . denotes .
T612 362-372 NN denotes suppressor
T611 356-361 NN denotes tumor
T610 354-355 DT denotes a
T609 351-353 IN denotes as
T608 340-350 VBN denotes considered
T607 337-339 VBZ denotes is
T606 333-336 CC denotes and
T605 325-332 NN denotes protein
T604 312-324 JJ denotes proapoptotic
T603 310-311 DT denotes a
T602 307-309 VBZ denotes is
T601 305-306 -RRB- denotes )
T600 301-305 CD denotes WOX1
T599 298-300 CC denotes or
T598 294-297 IN denotes FOR
T597 293-294 -LRB- denotes (
T596 288-292 NNP denotes WWOX
T595 273-287 NN denotes oxidoreductase
T594 255-272 JJ denotes domain-containing
T593 252-254 NNP denotes WW
T592 250-251 . denotes .
T591 245-250 NNS denotes drugs
T590 233-244 JJ denotes therapeutic
T589 229-232 CC denotes and
T588 227-228 -RRB- denotes )
T587 224-227 NNP denotes TMZ
T586 223-224 -LRB- denotes (
T585 210-222 VB denotes temozolomide
T584 207-209 TO denotes to
T583 196-206 NN denotes resistance
T582 193-195 TO denotes to
T581 191-192 , denotes ,
T580 187-191 NN denotes part
T579 184-186 IN denotes in
T578 182-183 , denotes ,
T577 172-182 VB denotes contribute
T576 169-171 TO denotes to
T575 161-168 VBZ denotes appears
T574 157-160 CC denotes and
T573 155-156 -RRB- denotes )
T572 151-155 NNS denotes GBMs
T571 150-151 -LRB- denotes (
T570 136-149 NNS denotes glioblastomas
T569 133-135 IN denotes in
T568 125-132 VBN denotes mutated
T567 114-124 RB denotes frequently
T566 110-113 VBP denotes are
T565 106-109 NN denotes p53
T564 95-105 NN denotes suppressor
T563 89-94 NNP denotes Tumor
T617 387-391 NN denotes gene
R265 T552 T554 compound Tumor,WWOX
R266 T553 T554 compound Suppressor,WWOX
R267 T554 T568 nsubjpass WWOX,mutated
R268 T555 T554 cc and,WWOX
R269 T556 T557 compound p53,Alterations
R270 T557 T554 conj Alterations,WWOX
R271 T558 T557 cc and,Alterations
R272 T559 T560 compound Drug,Resistance
R273 T560 T557 conj Resistance,Alterations
R274 T561 T557 prep in,Alterations
R275 T562 T565 compound Glioblastomas,p53
R276 T563 T565 compound Tumor,p53
R277 T564 T565 compound suppressor,p53
R278 T565 T561 pobj p53,in
R279 T566 T568 auxpass are,mutated
R280 T567 T568 advmod frequently,mutated
R281 T568 T568 ROOT mutated,mutated
R282 T569 T568 prep in,mutated
R283 T570 T569 pobj glioblastomas,in
R284 T571 T572 punct (,GBMs
R285 T572 T570 appos GBMs,glioblastomas
R286 T573 T568 punct ),mutated
R287 T574 T568 cc and,mutated
R288 T575 T568 conj appears,mutated
R289 T576 T577 aux to,contribute
R290 T577 T575 xcomp contribute,appears
R291 T578 T577 punct ",",contribute
R292 T579 T575 prep in,appears
R293 T580 T579 pobj part,in
R294 T581 T575 punct ",",appears
R295 T582 T583 aux to,resistance
R296 T583 T568 advcl resistance,mutated
R297 T584 T585 aux to,temozolomide
R298 T585 T583 advcl temozolomide,resistance
R299 T586 T587 punct (,TMZ
R300 T587 T585 appos TMZ,temozolomide
R301 T588 T587 punct ),TMZ
R302 T589 T585 cc and,temozolomide
R303 T590 T591 amod therapeutic,drugs
R304 T591 T585 conj drugs,temozolomide
R305 T592 T568 punct .,mutated
R306 T593 T596 compound WW,WWOX
R307 T594 T596 compound domain-containing,WWOX
R308 T595 T596 compound oxidoreductase,WWOX
R309 T596 T602 nsubj WWOX,is
R310 T597 T598 punct (,FOR
R311 T598 T596 prep FOR,WWOX
R312 T599 T598 cc or,FOR
R313 T600 T598 conj WOX1,FOR
R314 T601 T598 punct ),FOR
R315 T602 T602 ROOT is,is
R316 T603 T605 det a,protein
R317 T604 T605 amod proapoptotic,protein
R318 T605 T602 attr protein,is
R319 T606 T602 cc and,is
R320 T607 T608 auxpass is,considered
R321 T608 T602 conj considered,is
R322 T609 T608 prep as,considered
R323 T610 T612 det a,suppressor
R324 T611 T612 compound tumor,suppressor
R325 T612 T609 pobj suppressor,as
R326 T613 T602 punct .,is
R328 T615 T614 prep of,Loss
R329 T616 T618 compound WWOX,expression
R330 T618 T615 pobj expression,of
R442 T617 T618 compound gene,expression

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T529 17-21 Protein denotes WWOX
T546 26-29 Protein denotes p53
T550 379-402 Gene_expression denotes of WWOX gene expression
T541 310-332 Protein denotes a proapoptotic protein
T539 382-386 Protein denotes WWOX
T537 252-287 Protein denotes WW domain-containing oxidoreductase
T535 210-228 Entity denotes temozolomide (TMZ)
T534 301-305 Protein denotes WOX1
T532 252-292 Protein denotes WW domain-containing oxidoreductase WWOX
T531 354-372 Protein denotes a tumor suppressor
T526 233-250 Entity denotes therapeutic drugs
T525 89-109 Protein denotes Tumor suppressor p53
T523 224-227 Entity denotes TMZ
R262 T539 T550 themeOf WWOX,of WWOX gene expression

DLUT931

Id Subject Object Predicate Lexical cue
T397 17-21 Protein denotes WWOX
T398 26-29 Protein denotes p53
T415 30-41 Regulation denotes Alterations
T417 374-378 Negative_regulation denotes Loss
T416 392-402 Gene_expression denotes expression
T404 382-386 Protein denotes WWOX
T403 301-305 Protein denotes WOX1
T402 294-297 Protein denotes FOR
T401 288-292 Protein denotes WWOX
T400 252-287 Protein denotes WW domain-containing oxidoreductase
T399 106-109 Protein denotes p53
R212 T397 T415 themeOf WWOX,Alterations
R213 T398 T415 themeOf p53,Alterations
R214 T404 T416 themeOf WWOX,expression
R222 T416 T417 themeOf expression,Loss

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T447 17-21 Protein denotes WWOX
T448 26-29 Protein denotes p53
T465 30-41 Regulation denotes Alterations
T467 374-378 Negative_regulation denotes Loss
T466 392-402 Gene_expression denotes expression
T454 382-386 Protein denotes WWOX
T453 301-305 Protein denotes WOX1
T452 294-297 Protein denotes FOR
T451 288-292 Protein denotes WWOX
T450 252-287 Protein denotes WW domain-containing oxidoreductase
T449 106-109 Protein denotes p53
R230 T448 T465 themeOf p53,Alterations
R231 T454 T466 themeOf WWOX,expression
R236 T466 T467 themeOf expression,Loss

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T355 17-21 Protein denotes WWOX
T356 26-29 Protein denotes p53
T374 392-402 Gene_expression denotes expression
T373 374-378 Negative_regulation denotes Loss
T362 382-386 Protein denotes WWOX
T361 301-305 Protein denotes WOX1
T360 294-297 Protein denotes FOR
T359 288-292 Protein denotes WWOX
T358 252-287 Protein denotes WW domain-containing oxidoreductase
T357 106-109 Protein denotes p53
R204 T362 T374 themeOf WWOX,expression
R210 T374 T373 themeOf expression,Loss

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T390 26-29 http://www.uniprot.org/uniprot/P04637 denotes p53
T396 89-109 http://www.uniprot.org/uniprot/P04637 denotes Tumor suppressor p53
T391 106-109 http://www.uniprot.org/uniprot/P04637 denotes p53
T389 301-305 http://www.uniprot.org/uniprot/Q9NZC7 denotes WOX1
T388 294-297 http://www.uniprot.org/uniprot/Q9NZC7 denotes FOR
T382 288-292 http://www.uniprot.org/uniprot/Q9NZC7 denotes WWOX
T383 382-386 http://www.uniprot.org/uniprot/Q9NZC7 denotes WWOX
T381 17-21 http://www.uniprot.org/uniprot/Q9NZC7 denotes WWOX

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T118 17-21 Protein denotes WWOX
T119 26-29 Protein denotes p53
T120 106-109 Protein denotes p53
T121 252-287 Protein denotes WW domain-containing oxidoreductase
T122 288-292 Protein denotes WWOX
T123 294-297 Protein denotes FOR
T124 301-305 Protein denotes WOX1
T125 382-386 Protein denotes WWOX

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T166 0-5 NN denotes Tumor
T167 6-16 NN denotes Suppressor
T168 17-21 NN denotes WWOX
T169 22-25 CC denotes and
T170 26-29 NN denotes p53
T171 30-41 NN denotes Alterations
T172 42-45 CC denotes and
T173 46-50 NNP denotes Drug
T174 51-61 NNP denotes Resistance
T175 62-64 IN denotes in
T176 65-78 NN denotes Glioblastomas
T232 406-416 RB denotes frequently
T231 403-405 VB denotes is
T230 392-402 NN denotes expression
T229 387-391 NN denotes gene
T228 382-386 NN denotes WWOX
T227 379-381 IN denotes of
T226 374-378 NN denotes Loss
T225 362-372 NN denotes suppressor
T224 356-361 NN denotes tumor
T223 354-355 DT denotes a
T222 351-353 IN denotes as
T221 340-350 VB denotes considered
T220 337-339 VB denotes is
T219 333-336 CC denotes and
T218 325-332 NN denotes protein
T217 312-324 JJ denotes proapoptotic
T216 310-311 DT denotes a
T215 307-309 VB denotes is
T214 305-306 -RRB- denotes )
T213 301-305 NN denotes WOX1
T212 298-300 CC denotes or
T211 294-297 NN denotes FOR
T210 293-294 -LRB- denotes (
T209 288-292 NN denotes WWOX
T208 273-287 NN denotes oxidoreductase
T207 255-272 JJ denotes domain-containing
T206 252-254 JJ denotes WW
T205 245-250 NN denotes drugs
T204 233-244 JJ denotes therapeutic
T203 229-232 CC denotes and
T202 227-228 -RRB- denotes )
T201 224-227 NN denotes TMZ
T200 223-224 -LRB- denotes (
T199 210-222 NN denotes temozolomide
T198 207-209 TO denotes to
T197 196-206 NN denotes resistance
T196 193-195 TO denotes to
T195 191-192 -COMMA- denotes ,
T194 187-191 NN denotes part
T193 184-186 IN denotes in
T192 182-183 -COMMA- denotes ,
T191 172-182 VB denotes contribute
T190 169-171 TO denotes to
T189 161-168 VB denotes appears
T188 157-160 CC denotes and
T187 155-156 -RRB- denotes )
T186 151-155 NN denotes GBMs
T185 150-151 -LRB- denotes (
T184 136-149 NN denotes glioblastomas
T183 133-135 IN denotes in
T182 125-132 VB denotes mutated
T181 114-124 RB denotes frequently
T180 110-113 VB denotes are
T179 106-109 NN denotes p53
T178 95-105 NN denotes suppressor
T177 89-94 NN denotes Tumor
R28 T168 T166 arg1Of WWOX,Tumor
R29 T168 T167 arg1Of WWOX,Suppressor
R30 T168 T169 arg1Of WWOX,and
R31 T169 T175 arg1Of and,in
R32 T171 T170 arg1Of Alterations,p53
R33 T171 T172 arg1Of Alterations,and
R34 T172 T169 arg2Of and,and
R35 T174 T172 arg2Of Resistance,and
R36 T174 T173 arg1Of Resistance,Drug
R37 T176 T175 arg2Of Glioblastomas,in
R38 T179 T177 arg1Of p53,Tumor
R39 T179 T178 arg1Of p53,suppressor
R40 T179 T180 arg1Of p53,are
R41 T179 T182 arg2Of p53,mutated
R42 T179 T189 arg1Of p53,appears
R43 T179 T191 arg1Of p53,contribute
R44 T182 T180 arg2Of mutated,are
R45 T182 T181 arg1Of mutated,frequently
R46 T182 T183 arg1Of mutated,in
R47 T182 T188 arg1Of mutated,and
R48 T184 T183 arg2Of glioblastomas,in
R49 T184 T185 arg1Of glioblastomas,(
R50 T186 T185 arg2Of GBMs,(
R51 T187 T185 arg3Of ),(
R52 T189 T188 arg2Of appears,and
R53 T191 T189 arg2Of contribute,appears
R54 T191 T190 arg1Of contribute,to
R55 T191 T192 arg1Of contribute,","
R56 T191 T193 arg1Of contribute,in
R57 T191 T195 arg1Of contribute,","
R58 T191 T196 arg1Of contribute,to
R59 T194 T193 arg2Of part,in
R60 T197 T198 arg1Of resistance,to
R61 T197 T203 arg1Of resistance,and
R62 T199 T198 arg2Of temozolomide,to
R63 T199 T200 arg1Of temozolomide,(
R64 T201 T200 arg2Of TMZ,(
R65 T202 T200 arg3Of ),(
R66 T203 T196 arg2Of and,to
R67 T205 T203 arg2Of drugs,and
R68 T205 T204 arg1Of drugs,therapeutic
R69 T209 T206 arg1Of WWOX,WW
R70 T209 T207 arg1Of WWOX,domain-containing
R71 T209 T208 arg1Of WWOX,oxidoreductase
R72 T209 T210 arg1Of WWOX,(
R73 T209 T215 arg1Of WWOX,is
R74 T209 T220 arg1Of WWOX,is
R75 T209 T221 arg2Of WWOX,considered
R76 T211 T212 arg1Of FOR,or
R77 T212 T210 arg2Of or,(
R78 T213 T212 arg2Of WOX1,or
R79 T214 T210 arg3Of ),(
R80 T215 T219 arg1Of is,and
R81 T218 T215 arg2Of protein,is
R82 T218 T216 arg1Of protein,a
R83 T218 T217 arg1Of protein,proapoptotic
R84 T221 T219 arg2Of considered,and
R85 T221 T220 arg2Of considered,is
R86 T221 T222 arg1Of considered,as
R87 T225 T222 arg2Of suppressor,as
R88 T225 T223 arg1Of suppressor,a
R89 T225 T224 arg1Of suppressor,tumor
R90 T226 T227 arg1Of Loss,of
R91 T226 T231 arg1Of Loss,is
R93 T230 T227 arg2Of expression,of
R94 T230 T228 arg1Of expression,WWOX
R95 T230 T229 arg1Of expression,gene

GO-BP

Id Subject Object Predicate Lexical cue
T136 0-16 http://purl.obolibrary.org/obo/GO_0051726 denotes Tumor Suppressor
T139 46-61 http://purl.obolibrary.org/obo/GO_0042493 denotes Drug Resistance
T140 387-402 http://purl.obolibrary.org/obo/GO_0010467 denotes gene expression
T138 356-372 http://purl.obolibrary.org/obo/GO_0051726 denotes tumor suppressor
T137 89-105 http://purl.obolibrary.org/obo/GO_0051726 denotes Tumor suppressor

sentences

Id Subject Object Predicate Lexical cue
T79 0-78 Sentence denotes Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas
T81 252-373 Sentence denotes WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptotic protein and is considered as a tumor suppressor.
T80 89-251 Sentence denotes Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs.
T1 0-78 Sentence denotes Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas
T2 80-88 Sentence denotes Abstract
T3 89-251 Sentence denotes Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs.
T4 252-373 Sentence denotes WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptotic protein and is considered as a tumor suppressor.

simple1

Id Subject Object Predicate Lexical cue
T148 17-21 Protein denotes WWOX
T149 26-29 Protein denotes p53
T155 382-386 Protein denotes WWOX
T154 301-305 Protein denotes WOX1
T153 294-297 Protein denotes FOR
T152 288-292 Protein denotes WWOX
T151 252-287 Protein denotes WW domain-containing oxidoreductase
T150 106-109 Protein denotes p53